In the March issue of the American Journal of Gastroenterology, the American College of Gastroenterology has published updated recommendations for colorectal cancer (CRC) screening. Aasma Shaukat, M.D., M.P.H., from the University of Minnesota in Minneapolis, and colleagues updated the 2009…
Read More
Genotoxic E. coli implicated in causing colorectal cancer ‘caught in the act’
Escherichia coli bacteria are constitutive members of the human gut microbiota. However, some strains produce a genotoxin called colibactin, which is implicated in the development of colorectal cancer. While it has been shown that colibactin leaves very specific changes in…
Read More
Study shows aspirin before a diagnosis may lower colorectal cancer mortality
A new study finds that long-term aspirin use before a diagnosis of colorectal cancer (CRC) may be associated with lower CRC-specific mortality. The report that appears in JNCI: The Journal of the National Cancer Institute, suggests that the findings for…
Read More
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells
What are cancer stem cells? An early cancer diagnosis is associated with a higher chance of survival and even curability as compared to cancers that are diagnosed at a later stage. While this may be true, any cancer that has…
Read More
Erbitux
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ERBITUX® cetuximab (rmc) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about ERBITUX. It does not contain all the available information….
Read More
Does aspirin lower colorectal cancer risk in older adults? It depends on when they start.
Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long? There is substantial evidence…
Read More
The number and clonality of TCRs are associated with the prognosis of colorectal cancer
Colorectal cancer (CRC) is the third most common cancer in the world, with more than one and a half million new cases diagnosed annually. Approximately 20% of diagnosed stage II patients experience relapses after surgery. There is no marker yet…
Read More
Common hypertension medications may reduce colorectal cancer risk
Medications commonly prescribed to treat high blood pressure may also reduce patients’ colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal. Angiotensin converting enzyme inhibitor (ACE-i) or angiotensin II receptor blocker (ARB) medications…
Read More